Literature DB >> 10863251

Silver needle therapy for intractable low-back pain at tender point after removal of nucleus pulposus.

L Yi-Kai1, A Xueyan, W Fu-Gen.   

Abstract

OBJECTIVE: To examine the use of a new silver needle therapy for treating tender points involved in intractable low-back pain after removal of nucleus pulposus.
SUBJECTS: The study involved 24 patients (17 men and 7 women) aged 26 to 67 years with a mean age of 54.5 +/- 5 years. SETTINGS: The Department of Orthopedics at the First Military Medical University, the Department of Rehabilitation Medicine at the General Hospital of PLA in Beijing, and the Department of Acupuncture, the First People's Hospital in Kunming City, People's Republic of China, were the settings for this study.
METHODS: The patients were treated with traditional silver needle therapy at tender points in the low back and buttocks. Pain at each of the tender points was measured before and after treatment; the scores were compared with a Student t test.
RESULTS: The therapeutic results suggest that the total scores for each tender point after treatment were significantly lower than those taken before treatment (P <.001).
CONCLUSION: Silver needle therapy shows promise for treating low-back pain after surgery for disc herniation. Further clinical trials are needed to confirm the effectiveness of this treatment.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10863251     DOI: 10.1067/mmt.2000.106869

Source DB:  PubMed          Journal:  J Manipulative Physiol Ther        ISSN: 0161-4754            Impact factor:   1.437


  2 in total

1.  Efficacy of silver needle therapy for the treatment of chronic nonspecific low back pain: a prospective, single-center, randomized, parallel-controlled clinical trial.

Authors:  Xuesong Hu; Shaoxing Dong; Bing Zhang; Xuan Wang; Yanwei Yin; Chuansheng Liu; Junmin Yu; Xing Wu; Fenghu Xu; Chao Meng
Journal:  Trials       Date:  2021-01-21       Impact factor: 2.279

2.  The efficacy and safety of silver needle in the treatment of rheumatoid arthritis: A protocol of randomized controlled trial.

Authors:  Jinling Yu; Pingsheng Wang; Cui Nie; Bo Zheng
Journal:  Medicine (Baltimore)       Date:  2021-05-07       Impact factor: 1.889

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.